ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

RNLX Renalytix PLC

0.5793
-0.0857 (-12.89%)
15 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Renalytix PLC RNLX NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0857 -12.89% 0.5793 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.665 0.5116 0.68 0.567 0.665
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
15/5/202409:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/5/202408:23EDGAR2Form 8-K - Current report
15/5/202406:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202406:00EDGAR2Form 8-K - Current report
15/5/202406:00GLOBERenalytix Reports Financial Results for Third Quarter of..
09/5/202406:00GLOBERenalytix to Report Financial Results for Third Quarter..
08/4/202406:00GLOBERenalytix Announces Financing with Expected Size of up to $4..
14/3/202406:00GLOBEKidneyIntelX™ included in Final KDIGO 2024 Clinical..
15/2/202406:00GLOBERenalytix Reports Financial Results for Second Quarter of..
15/2/202406:00EDGAR2Form 8-K - Current report
14/2/202415:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/2/202408:00GLOBERenalytix to Participate in the BTIG MedTech, Digital..
17/1/202406:15EDGAR2Form 8-K - Current report
10/1/202406:15EDGAR2Form 8-K - Current report
10/1/202406:00GLOBENew published data demonstrates KidneyIntelX™ has broad..
29/12/202315:02EDGAR2Form 8-K - Current report
17/11/202315:01EDGAR2Form ARS - Annual Report to Security Holders
14/11/202306:00GLOBERenalytix Reports Financial Results for First Quarter of..
07/11/202306:00GLOBERenalytix to Report Financial Results for First Quarter..
03/11/202315:04EDGAR2Form PRE 14A - Other preliminary proxy statements
24/10/202307:00EDGAR2Form 8-K - Current report
06/10/202306:00GLOBEUS Patent Office Allows Patent Claims for Intellectual..
28/9/202306:00GLOBERenalytix Reports Full Year Fiscal 2023 Results
25/9/202306:00GLOBERenalytix to Report Financial Results for Fourth Quarter and..
08/9/202315:04EDGAR2Form 8-K - Current report
07/9/202306:00GLOBERenalytix Appoints Senior Executive Howard Doran as Chief..
03/8/202306:00GLOBERenalytix Clinical Advisory Board Formed to Support..
21/7/202306:00GLOBERenalytix Announces Middle East Distribution Agreement with..
07/7/202306:00GLOBELate-Breaking KidneyIntelX Evidence Released at 83rd..
03/7/202306:00GLOBERenalytix Appoints Financial Executive Catherine Coste to..
29/6/202317:58DJNRenalytix Gets FDA De Novo Marketing Authorization for..
29/6/202317:01GLOBEFDA Grants De Novo Marketing Authorization for..
15/6/202306:00GLOBEKidneyIntelX™ Clinical Decision Impact / Validation and..
09/6/202306:00GLOBERenalytix Reports Financial Results for Third Quarter of..
05/6/202306:00GLOBERenalytix to Report Third Quarter Fiscal Year 2023 Financial..
25/5/202306:00GLOBERenalytix selects EVERSANA® to expand commercialization of..